LeeAnn Shiveley Selected Research

apricitabine

1/2008	Multiple-dose pharmacokinetics of apricitabine, a novel nucleoside reverse transcriptase inhibitor, in patients with HIV-1 infection.
6/2006	Efficacy and tolerability of 10-day monotherapy with apricitabine in antiretroviral-naive, HIV-infected patients.
1/2006	Pharmacokinetics of single oral doses of apricitabine, a novel deoxycytidine analogue reverse transcriptase inhibitor, in healthy volunteers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

LeeAnn Shiveley Research Topics

Disease

2	Infections 01/2008 - 01/2006
1	HIV Infections (HIV Infection) 06/2006

Drug/Important Bio-Agent (IBA)

3	apricitabineIBA 01/2008 - 01/2006
2	DeoxycytidineIBA 01/2008 - 01/2006
2	Reverse Transcriptase InhibitorsIBA 01/2008 - 01/2006
1	NucleosidesIBA 01/2008
1	RNA (Ribonucleic Acid)IBA 06/2006

Therapy/Procedure

1	Therapeutics 06/2006